3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Tract Infections
1
Urinary Bladder, Neurogenic
1
Spinal Cord Injuries
1
Myelitis, Transverse
1
Multiple Sclerosis
1
Interventions
fludarabine
2
Fingolimod Hydrochloride
2
Cyclophosphamide
2
Blood Specimen Collection
2
teriflunomide
1
gadobutrol
1
gadobenic acid
1
Surveys and Questionnaires
1
Specimen Handling
1
Respiratory Therapy
1
Registries
1
Platelet Transfusion
1
Phlebotomy
1
OM 89
1
Nivolumab
1
Natalizumab
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Interferon beta-1a
1
Gadolinium DTPA
1
Fish Oils
1
Exergaming
1
Dimethyl Fumarate
1
Dietary Fiber
1
Data Collection
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Multiple Sclerosis
×
OM 89
×
Clear all
NCT02591901
2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2
Completed
48 enrolled